Bausch & Lomb (BLCO) Other Non Operating Income (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Other Non Operating Income came in at -$5.0 million in Q2 2026, up 44.44% YoY from -$3.5 million in Q2 2025, and down 66.67% on a QoQ basis from -$3.0 million in Q1 2026.
Bausch & Lomb (BLCO) Other Non Operating Income (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Other Non Operating Income data on file, last reported at -$5.0 million in Q2 2026.
- Quarterly Other Non Operating Income rose 44.44% year-over-year to -$5.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$15.0 million (up 37.5% YoY) and the FY2025 annual result came in at -$15.0 million, down 25.0% from the prior year.
- Other Non Operating Income retreated to -$5.0 million in Q2 2026, from -$3.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $14.0 million in Q2 2022 to a low of -$10.0 million in Q4 2023.
- A 5-year average of -$3.8 million and a median of -$5.0 million in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 200.0% — and 2025, when it sank 200.0%.
- Tracing BLCO's Other Non Operating Income over 5 years: stood at -$9.0 million in 2022, then retreated by 11.11% to -$10.0 million in 2023, then soared by 60.0% to -$4.0 million in 2024, then changed by 0.0% to -$4.0 million in 2025, then retreated by 25.0% to -$5.0 million in 2026.
- The last three Other Non Operating Income figures came in at -$5.0 million (Q2 2026), -$3.0 million (Q1 2026), and -$4.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -9.00 Mn |
| Mar 31, 2025 | -6.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Dec 31, 2023 | -10.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -9.00 Mn |
| Mar 31, 2023 | -6.00 Mn |
| Dec 31, 2022 | -9.00 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | -5.00 Mn |
| Dec 31, 2021 | -6.00 Mn |
| Sep 30, 2021 | -6.00 Mn |
| Jun 30, 2021 | 9.00 Mn |